ASJ Inc (2351)

Tokyo

Currency in JPY

302.0

-2.0(-0.66%)

Closed·23/05

Fair Value

Unlock Value

Day's Range

301.0

308.0

52 wk Range

271.0

572.0

ASJ (2351) Income Statement & Profits

Assess the ASJ Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

Total Revenues

aa.aa

2,506

2,491

2,753

2,846

2,741

Total Revenues Growth

aa.aa

+0.97%

-0.6%

+10.52%

+3.38%

-3.69%

Cost Of Revenues

aa.aa

1,598

1,605

1,722

1,737

1,623

Gross Profit

aa.aa

908

886

1,031

1,109

1,118

Gross Profit Growth

aa.aa

+15.08%

-2.42%

+16.37%

+7.57%

+0.81%

Gross Profit Margin %

aa.aa

36.23%

35.57%

37.45%

38.97%

40.79%

Other Operating Expenses, Total

aa.aa

863

873

953

1,007

957

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+12.81%	+1.16%	+9.16%	+5.67%	-4.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	47	53	58	59	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	759	799	857	908	960
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9	2	-4	-4	-3

Operating Income

aa.aa

102

161

Operating Income Growth

aa.aa

+87.5%

-71.11%

+500%

+30.77%

+57.84%

EBIT Margin %

aa.aa

1.8%

0.52%

2.83%

3.58%

5.87%

Net Interest Expenses

aa.aa

Net Interest Expenses Growth

aa.aa

-50%

+100%

+25%

+40%

-57.14%

Interest Expense, Total

aa.aa

-2

-1

-5

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-1

EBT, Excl. Unusual Items

aa.aa

110

164

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-5

-502

EBT, Incl. Unusual Items

aa.aa

-481

110

164

EBT, Incl. Unusual Items Growth

aa.aa

+85.71%

-1,025%

+117.05%

+34.15%

+49.09%

EBT, Incl. Unusual Items Margin

aa.aa

2.08%

-19.31%

2.98%

3.87%

5.98%

Income Tax Expense

aa.aa

-2

-82

Net Income to Company

aa.aa

-484

112

246

Minority Interest

aa.aa

Net Income

aa.aa

-484

112

246

Net Income Growth

aa.aa

+79.17%

-1,225.58%

+112.81%

+80.65%

+119.64%

Net Income Margin %

aa.aa

1.72%

-19.43%

2.25%

3.94%

8.97%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-484

112

246

Basic EPS - Continuing Operations

aa.aa

5.47

-61.05

7.8

14.09

30.94

Basic EPS - Continuing Operations Growth

aa.aa

+78.96%

-1,216.23%

+112.77%

+80.65%

+119.64%

Diluted EPS - Continuing Operations

aa.aa

5.47

-61.13

7.8

14.09

30.94

Diluted EPS - Continuing Operations Growth

aa.aa

+78.96%

-1,217.6%

+112.76%

+80.65%

+119.64%

Basic Weighted Average Shares Outstanding

aa.aa

7.86

7.93

7.95

Diluted Weighted Average Shares Outstanding

aa.aa

7.95

7.93

7.95

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

344

332

361

375

424

EBITDA Growth

aa.aa

+21.13%

-3.49%

+8.73%

+3.88%

+13.07%

EBITDA Margin %

aa.aa

13.73%

13.33%

13.11%

13.18%

15.47%

EBIT

aa.aa

102

161

* In Millions of JPY (except for per share items)

FTSE 100

8,717.97

-21.29

-0.24%

DAX

23,629.58

-369.59

-1.54%

Euro Stoxx 50

5,326.31

-98.17

-1.81%

S&P 500

5,802.82

-39.19

-0.67%

Nikkei 225

37,160.47

+174.60

+0.47%

Dow Jones

41,603.07

-256.02

-0.61%

FTSE 100 Futures

8,739.80

-28.3

-0.32%

Market Movers

Name	Last	Chg. %	Vol.
BP	356.20	-0.17%	68.76M
HSBC	868.80	-1.34%	26.11M
Anglo American	2,191.5	+3.37%	13.39M
Shell	2,420.0	-0.82%	12.14M
British American Tobacco	3,335.0	+1.24%	8.50M
Reckitt Benckiser	4,929.0	+0.39%	4.71M
AstraZeneca	10,436.0	+0.60%	3.09M

Name	Last	Chg. %	Vol.
Inteliqo	0.03	+400.99%	0.00
Iconic Labs	3.5000	+89.19%	11.89M
Medincell	16.30	+86.29%	0.00
Defence Holdings	0.50	+72.41%	138.99M
Mast Energy Developments	0.51	+46.24%	82.13M
Smarter Web	0.69	+39.39%	0.00
Coinsilium Group	0.05	+35.44%	0.00

Name	Last	Chg. %	Vol.
Tectonic Gold	0.002	-94.29%	0.00
Totally	0.30	-79.30%	30.14M
Semperit AG Holding	13.60	-41.38%	0.00
ChallengerX plc	0.25	-37.50%	400.00K
Schweizerische Nationalbank	3,170.00	-30.48%	1.00
Phaxiam Therapeutics	0.21	-27.78%	24.07K
GS Chain	0.38	-26.00%	606.10K

Trending Stocks

Name	Last	Chg. %	Vol.
AstraZeneca	10,436.0	+0.60%	3.09M
Rolls-Royce Holdings	835.80	-0.38%	26.92M
HSBC	868.80	-1.34%	26.11M
Phoenix	633.00	+0.88%	3.75M
National Grid	1,091.00	+0.23%	8.18M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa A Aa A Aa	1,425.50	+46.38%	2,086.65
Aaaa Aaaaa	356.20	+32.17%	470.79
Aaaaaaa Aaa	158.60	+25.55%	199.12
Aaaaaaaa	10,436.0	+24.79%	13,023.08
Aaaaaa	4,562.5	+23.69%	5,643.36
Aaaa Aaaaa	3,335.0	+18.99%	3,968.32
Aaaaaaaaaaaa	2,076.00	+18.74%	2,465.04

Name	Last	Upside	Fair Value
Aa A Aa A Aa	1,425.50	+46.38%	2,086.65
Aaaa Aaaaa	356.20	+32.17%	470.79
Aaaaaaa Aaa	158.60	+25.55%	199.12
Aaaaaaaa	10,436.0	+24.79%	13,023.08
Aaaaaa	4,562.5	+23.69%	5,643.36
Aaaa Aaaaa	3,335.0	+18.99%	3,968.32
Aaaaaaaaaaaa	2,076.00	+18.74%	2,465.04

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

ASJ Inc (2351)

ASJ (2351) Income Statement & Profits

Trending Stocks